Oxidative stress in liver transplant recipients

Annals of Transplantation

Volumn 16, Issue 1, 2011, Pages 99-108

  Czubkowski, Piotr ^a   Socha, Piotr ^a   PawŁowska, Joanna ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Antioxidant treatment; Liver transplant recipients; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; BETA CAROTENE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; EVEROLIMUS; HEAT SHOCK PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTAGLANDIN E1; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; TACROLIMUS;

ACUTE LIVER FAILURE; ALCOHOL LIVER CIRRHOSIS; ANTIOXIDANT ACTIVITY; BILE DUCT ATRESIA; CHOLESTASIS; COLD ISCHEMIA; DNA DAMAGE; DRUG ANTAGONISM; DRUG POTENTIATION; ENZYME MECHANISM; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; LIVER CIRRHOSIS; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PEROXIDATION; REPERFUSION INJURY; REVIEW;

ACETYLCYSTEINE; ANTIOXIDANTS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; RISK FACTORS;

EID: 79953272568     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Kaplowitz N: Mechanisms of liver injury. J Hepatol, 2000: 32: 39-47
2. Halliwell B, Evans PJ, Kaur H, Aruoma O: Free radicals, tissue injury and human disease: a potential for therapeutic use of antioxidants. In: Kinney JM, Tucker HN, eds. Organ Metabolism and Nutrition: Ideas for Future Critical Care. New York, NY: Raven Press, 1994; 425-45
3. Glantzounis GK, Salacinski HJ, Yang W et al: The Contemporary Role of Antioxidant Therapy in Attenuating Liver Ischemia-Reperfusion Injury: A Review. Liver Transpl, 2005; 11: 1031-1047
4. Koningsberger JC, Marx JJM, Hattum JV: Free Radicals in Gastroenterology. Scand J Gastroenterol, 1988; 23: 30-40
5. Gardner HW: Oxygen radical chemistry of polyunsaturated fatty acids. Free Radic Biol Med, 1989; 7: 65-86
6. Chirico S: High performance liquid chromatography- based thiobarbituric acid tests. Methods Enzymol, 1994; 233: 314-318
7. Frank H, Hintze T, Bimboes D, Remmer H: Monitoring lipid peroxidation by breath analysis. Endogenous hydrocarbons and their metabolic elimination. Toxicol Appl Pharmacol, 1980; 56: 337-344
8. Esterbauer J, Jurgens G, Queenberger O, Koller A: Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res, 1987; 28: 495-509
9. Risby TH, Maley W, Scott RP et al: Evidence for free radical-mediated lipid peroxidation at reperfusion of human orthotopic liver transplants. Surgery, 1994; 115(1): 94-101
10. Esterbauer H, Striegl G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun, 1989: 6: 67-75
11. Paiva H, Laakso J, Ruokonen I et al: Plasma asymmetric dimethylarginine (ADMA), nitrate and the indices of low-density lipoprotein oxidation. Clin Chem Acta, 2006; 371: 97-101
12. Reznick AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol, 1994; 233: 357-363
13. Cooke MS, Evans M, Dizdaroglu M, Lunec J: Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J, 2003; 17: 1195-1214
14. Tanaka H, Fujita N, Sugimoto R et al: Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C. Br J Cancer, 2008; 98: 580-586
15. Trevisani F, Caraceni P, Simoncini M et al: Evidence of oxidative imbalance in long-term liver transplant patients. Diget Liver Dis, 2002; 34: 279-284
16. Corradini SG, Micheletta F, Natoli S et al: High preoperative recipient plasma 7beta-hydroxycholesterol is associated with initial poor graft function after liver transplantation. Liver Transpl, 2005; 11(12): 1494-1504
17. Leung PS, Rossaro L, Davis PA et al: Antimitochondrial antibodiesin acute liver failure: implications for primary biliary cirrhosis. Hepatology, 2007; 46(5): 1436-1442
18. Waluga M, Hartleb M: Alcoholic liver disease. Wiad Lek, 2003; 56(1-2): 61-70
19. McCartney EM, Beard MR: Impact of alcohol on hepatitis C virus replication and interferon signaling. World J Gastroenterol, 2010; 16(11): 1337-1343
20. Pal S, Polyak SJ, Bano N et al: Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL 1. J Gastro Hepatol, 2010; 25: 627-634
21. Younossi ZM: Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther, 2008; 28: 2-12
22. Sokol RJ, Devereaux M, Dahl R, Gumpricht E: "Let There Be Bile" Understanding Hepatic Injury in Cholestasis. J Pediatr Gastroenterol Nutr, 2006; 43(1): S4-S9
23. Mao-Meng T, Tsu-Ksung L, Fang-Ying K et al: Early stage of biliary atresia is associated with significant changes in 8-hydroxydeoxyguanosine and mitochondrial copy number. J Pediatr Gastr Nutr, 2007; 45: 329-334
24. Broide E, Klinowski E, Koukoulis G et al: Superoxide dismutase activity in children with chronic liver disease. J Hepatology, 2000; 32: 188-192
25. Floreani A, Baragiotta A, Martines R et al: Plasma antioxidant levels in chronic cholestatic lliver diseases. Aliment Pharmacol Ther, 2000; 14: 353-358
26. Pessayre D, Mansouri A, Fromenty B: Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol, 2002: 282: G193-G199
27. Sokol RJ, Winklhofer-Roob BM, Devereaux MW et al: Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology, 1995; 109: 1249-1256
28. Rodrigues CM, Steer CJ: Mitochondrial membrane perturbations in cholestasis. J Hepatol, 2000; 32: 135-141
29. Sakrak O, Akpinar M, Bedirli A et al: Short and long-term effects of bacterial translocation due to obstructive jaundice on liver damage. Hepatogastroenterology, 2003; 50(53): 1542-1546
30. Thuy S, Ladurner R, Volynets V et al: Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr, 2008; 138(8): 1452-1455
31. Bellot P, García-Pagán JC, Francés R et al: Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology, 2010; 52(6): 2044-2052
32. Such J, Francés R, Muñoz C et al: Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology, 2002; 36(1): 135-141
33. Wong F, Bernardi M, Balk R et al; International Ascites Club: Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut, 2005; 54(5): 718-725
34. Socha P, Koletzko B, Pawlowska J et al: Treatment of cholestatic children with water-soluble vitamin E (alpha-tocopheryl polyethylene glycol succinate): effects on serum vitamin E, lipid peroxides, and polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr, 1997; 24(2): 189-193
35. Codoner-Franch P, Muniz P, Gasco E et al: Effect of diet supplemented with alpha-tocopherol and b-carotene on ATP and antioxidant levels after hepatic ischemia-reperfusion. J Clin Biochem Nutr, 2008; 43: 13-18
36. Clavien PA, Harvey PR, Strasberg SM: Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation, 1992; 53: 957-978
37. Miyagawa Y, Imamura H, Soeda J et al: Fate of hepatocyte and sinusoidal lining cell function and kinetics after extended cold preservation and transplantation of the rat liver. Liver Transpl, 2002; 8: 370-381
38. Serrano E, Diaz J, Acosta F et al: Oxidative Stress During Ischemia-Reperfusion in Liver Transplantation. Transp Proc, 2000; 32: 2651
39. Rudiger HA, Clavien PA: Tumor necrosis factoralpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology, 2002; 122: 202-210
40. Jaeschke H, Farhood A: Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol, 1993; 264: G801-G809
41. Jaeschke H: Kupffer cell-induced oxidant stress during hepatic ischemia-reperfusion: does the controversy continue? Hepatology, 1999; 30: 1527-1528
42. Nieminen AL, Byrne AM, Herman B, Lemasters JJ: Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am J Physiol, 1997; 272: C1286-C1294
43. Liu TZ, Lee KT, Chern CL et al: Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. Ann Clin Lab Sci, 2001; 31: 383-390
44. Bauer M, Bauer I: Heme oxygenase-1: Redox regulation and role in the hepatic response to oxidative stress. Antioxid Redox Signal, 2002; 4: 749-758
45. Pannen BH: New insights into the regulation of hepatic blood flow after ischemia and reperfusion. Anesth Analg, 2002; 94: 1448-1457
46. Nakatani T, Inouye M, Mirochnitchenko O: Overexpression of antioxidant enzymes in transgenic mice decreases cellular ploidy during liver regeneration. Exp Cell Res, 1997; 236: 137-146
47. Kauser K, Rubanyi GM: Potential cellular signaling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen. J Vasc Res, 1997; 34: 229-236
48. Foster PF, Sankary HN, Hart M et al: Blood and graft eosinophilia as predictors of rejection in human liver transplantation. Transplantation, 1989; 47: 72-74
49. Nagral A, Ben-Ari Z, Paul A et al: Eosinophils in Acute Cellular Rejection in Liver Allografts. Liver Transpl Surg, 1998; 4(5): 355-362
50. Salunga TL, Cui ZG, Shimoda S et al: Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun, 2007; 29: 78-86
51. Colletti LM, Remick DG, Burtch GD et al: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest, 1990; 85: 1936-1943
52. Nagakawa Y, Williams GM, Zheng Q et al: Oxidative mitochondrial DNA damage and deletion in hepatocytes of rejecting liver allografts in rats: role of TNF-alpha. Hepatology, 2005; 42(1): 208-215
53. Granot E, Elinav H, Kohen R: Markers of Oxidative Stress in Cyclosporine-Treated and Tacrolimus- Treated Children After Liver Transplantation. Liver Transpl, 2002; 8: 469-475
54. Christians U, Gottschalk S, Miljus J et al: Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors. Br J Pharmacol, 2004; 143(3): 388-396
55. Garcia-Criado FJ, Palma-Vargas JM, Valdunciel- Garcia JJ et al: Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. Transplantation, 1997; 64(4): 594-598
56. Perrea DN, Moulakakis KG, Poulakou MV et al: Correlation between oxidative stress and immunosuppressive therapy in renal transplant recipients with an uneventful postoperative course and stable renal function. Int Urol Nephrol, 2006; 38(2): 343-348
57. Halcox JP, Schenke WH, Zalos G et al: Prognostic value of coronary vascular endothelial dysfunction. Circulation, 2002; 106: 653-658
58. Krotz F, Keller M, Derflinger S et al: Mycophenolate Acid Inhibits Endothlial NAD(P)H Oxidase Activity and Superoxide Formation by a Rac1-Dependent Mechanism. Hypertension, 2007: 49: 201-208
59. Trapp A, Weis M: The Impact of Immunosuppression on Endothelial Function. Journal of Cardiovascular Pharmacology, 2005; 45(1): 81-87
60. Cofan B, Campos R, Guerra J-M et al: Effect of Calcineurin Inhibitors on Low-Density Lipoprotein Oxidation F. Transplant Proceed, 2005; 37: 3791-3793
61. Wierzbicka A, Pawłowska J, Socha P et al: Lipid, carbohydrate metabolism, and antioxidant status in children after liver transplantation. Transplant Proc, 2007; 39(5): 1523-1525
62. Selzner N, Rudiger H, Graf R, Clavien PA: Protective Strategies Against Ischemic Injury of the Liver. Gastroenterology, 2003; 125: 917-936
63. Yan S, Jin L-M, Liu Y-X et al: Outcomes and mechanisms of ischemic preconditioning in liver transplantation. Hepatobiliary Pancreat Dis Int, 2010; 9: 346-354
64. Rüdiger HA, Graf R, Clavien PA: Sub-lethal oxidative stress triggers the protective effects of ischemic preconditioning in the mouse liver. J Hepatol, 2003; 39(6): 972-977
65. Sindram D, Rudiger HA, Upadhya AG et al: Ischemic preconditioning protects against cold ischemic injury through an oxidative stress dependent mechanism. J Hepatol, 2002; 36: 78-84
66. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 1986; 74: 1124-1136
67. Amador A, Grande L, Mart'I J et al: Ischemic Preconditioning in Deceased Donor Liver Transplantation: A Prospective Randomized Clinical Trial. Am J Transplant, 2007; 7(9): 2180-2189
68. Koneru B, Shareef A, Dikdan G et al: The Ischemic Preconditioning Paradox in Deceased Donor Liver Transplantation - Evidence from a Prospective Randomized Single Blind Clinical Trial. Am J Transplant, 2007; 7(12): 2788-2796
69. Franco-Gou R, Roselló-Catafau J, Casillas-Ramirez A et al: How ischaemic preconditioning protects small liver grafts. J Pathol, 2006; 208(1): 62-73
70. Ishikawa Y, Yamamoto Y, Kume M et al: Heat shock preconditioning on mitochondria during warm ischemia in rat livers. J Surg Res, 1999; 87: 178-184
71. Terajima H, Enders G, Thiaener A et al: Impact of hyperthermic preconditioning on postischemic hepatic microcirculatory disturbances in an isolated perfusion model of the rat liver. Hepatology, 2000; 31: 407-415
72. Saad S, Kanai M, Awane M: Protective effect of heat shock pretreatment with heat shock protein induction before hepatic warm ischemia injury caused by Pringel's maneuver. Surgery, 1995; 118: 510
73. Coito AJ, Buelow R, Shen XD et al: Heme-oxygenase- 1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia reperfusion injury. Transplantation, 2002; 74: 96-102
74. Jin X, Zhang Z, Beer-Stolz D et al: Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology, 2007: 46(3): 802-812
75. Rehman H, Connor HD, Ramshesh VK et al: Ischemic preconditioning prevents free radical production and mitochondrial depolarization in smallfor - size rat liver grafts. Transplantation, 2008; 85: 1322-1331
76. Harrison PM, Hughes RD, Forbes A et al: Improved outcome of paracetamol-induced acute liver failure (ALF) by late administration of acetylocysteine. Lancet, 1990; 335: 1572-1573
77. Hattori H, Higushi Y, Tsuji M et al: Living-related liver transplantation and neurological outcome in children with fulminant hepatic failure. Transplantation, 1998; 65: 686-692
78. San-Miguel B, Alvarez M, Culebras JM et al: Nacetyl- cysteine protects liver from apoptotic death in an animal model of fulminant hepatic failure. Apoptosis, 2006; 11(11): 1945-1957
79. Winniford MD, Kennedy PL, Wells PJ, Hillis LD: Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine. Circulation, 1986; 73: 138-142
80. Glantzounis GK, Yang W, Koti RS et al: Continuous infusion of N-acetylcysteine reduces liver warm ischaemia-reperfusion injury. Br J Surg, 2004; 91: 1330-1339
81. Weigand MA, Plachky J, Thies JC et al: N-acetylcysteine attenuates the increase in alpha-glutathione S-transferase and circulating ICAM-1 and VCAM-1 after reperfusion in humans undergoing liver transplantation. Transplantation, 2001; 72: 694-698
82. Santiagoc FM, Buenoa P, Olmedoa C et al: Effect of N-Acetylcysteine Administration on Intraoperative Plasma Levels of Interleukin-4 and Interleukin- 10 in Liver Transplant Recipients. Transplant Proc, 2008; 40(9):2978-2980
83. Santiagoc FM, Olmedoa C, Muffak-Granerob K et al: Ferrónb Intraoperative pH Values After Nacetylcysteine Administration During Liver Transplantation, 2010; 42(8): 3164-3166
84. Tahan G, Tarcin O, Tahan V et al: The effects of N-acetylcysteine on bile duct ligation-induced liver fibrosis in rats. Dig Dis Sci, 2007; 52(12): 3348-3354
85. Bucuvalas JC, Ryckman FC, Krug S et al: Effect of treatment with prostaglandin E1 and N-acetylcysteine on pediatric liver transplant recipients: a singlecenter study. Pediatr Transplant, 2001; 5: 274-278
86. Khan AW, Fuller BJ, Shah SR et al: A prospective randomized trial of N-acetyl cysteine administration during cold preservation of the donor liver for transplantation. Ann Hepatol, 2005; 4: 121-126
87. Samonte V, Sherman P, Taylor G et al: Scurvy diagnosed in a paediatric liver transplant patient awaiting combined kidney and liver transplantation. 2008; 12(3): 363-367
88. Socha P, Litwin M: Scurvy diagnosed in a pediatric liver transplant awaiting combined kidney and liver transplantation. Pediatr Transplant, 2008: 12(3): 257-260
89. Socha P, Koletzko B, Pawłowska J et al: Treatment of cholestatic children with water soluble vitamin E (alfa-tocopheryl polyethylene glycol succinate). Effects on serum vitamin E, lipid peroxides and polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr, 1997; 24: 189-193
90. Granot E, Kohen R: Oxidative stress in childhood in health and disease states. Clinical Nutrition, 2004; 23: 3-11
91. Mailila N, Virtamo J, Virtanen M et al: The effect of alpha-tocopherol and betacarotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev, 1999; 8: 489-493
92. Rautalahti MT, Virtamo JR, Taylor PR et al: The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. Cancer, 1999; 86: 37-42
93. Leppala JM, Virtamo J, Fogelholm R et al: Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol, 2000; 20: 230-235
94. Olthoff KM: Molecular pathways of regeneration and repair after liver transplantation. World J Surg, 2002; 26: 831-837